Keyphrases
Inhaled Corticosteroids
72%
Asthma
70%
Impulse Oscillometry
53%
Spirometry
35%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Asthma Control
31%
Long-acting beta-agonists
30%
Persistent Asthma
24%
Reactance
22%
Asthma Control Questionnaire
22%
Particle Size
20%
Fractional Exhaled Nitric Oxide (FeNO)
19%
Bisoprolol
18%
Extrafine Particle
18%
β2-agonists
18%
Carvedilol
17%
Long-acting muscarinic Antagonist
17%
Airway Hyperresponsiveness
16%
Bronchoconstriction
16%
Tiotropium
15%
ICS-LABA
15%
Peak Flow
14%
Moderate to Severe
14%
Asthma Patients
13%
Mannitol
13%
Corticosteroid Dose
12%
Confidence Interval
12%
Lung Compliance
11%
Blood Eosinophilia
11%
Beta-blockers
11%
Tolerability
11%
Salbutamol
11%
Pulmonary Function
11%
Asthmatic
11%
Clinical Practice
10%
Pragmatic Assessment
10%
Respiratory Impedance
10%
Comparative Bias
10%
Impedance Measurement
10%
Single-inhaler Triple Therapy
10%
Blood Response
10%
Typical Symptoms
10%
Lung Resistance
10%
Eosinophilic Asthma
10%
Cardiopulmonary Interactions
10%
Efficacy Profile
10%
Indacaterol
10%
Non-associated
10%
Severe Persistent Asthma
10%
Olodaterol
10%
Medicine and Dentistry
Asthma
55%
Chronic Obstructive Pulmonary Disease
40%
Beta Adrenergic Receptor Stimulating Agent
29%
Oscillometry
28%
Beta Adrenergic Receptor Blocking Agent
20%
Airway Resistance
18%
Respiratory Tract Allergy
18%
Carvedilol
17%
Eosinophil
15%
Lung
14%
Muscarinic Antagonist
12%
Eosinophilic
11%
Spirometry
10%
Bronchoconstriction
10%
Mannitol
10%
Receptor
10%
Olodaterol
10%
Benralizumab
10%
Randomized Controlled Trial
10%
Dose Response
10%
Nitric Oxide
9%
Bisoprolol
8%
Forced Expiratory Volume
8%
Eosinophilia
8%
Salbutamol
8%
Lung Function
7%
Peak Expiratory Flow
6%
Quality of Life
6%
Arginine
6%
Low Drug Dose
6%
Family History
5%
Atopy
5%
Wheeze
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Chronic Obstructive Lung Disease
40%
Beta Adrenergic Receptor Stimulating Agent
21%
Respiratory Tract Allergy
19%
Bisoprolol
18%
Beta 2 Adrenergic Receptor Stimulating Agent
18%
Muscarinic Receptor Blocking Agent
16%
Salbutamol
13%
Mannitol
13%
Tolerability
11%
Inflammation
11%
Receptor
11%
Carvedilol
10%
Benralizumab
10%
Beta Adrenergic Receptor Blocking Agent
10%
Indacaterol
10%
Olodaterol
10%
Randomized Controlled Trial
10%
Arginine
7%